Skip to main content

Ramsay David A's Form 4 filing

La Jolla Pharmaceutical Co (LJPC) · filed Dec 6, 2021

Accession no.
0001209191-21-068221
Filed
Dec 6, 2021
Trade date
Dec 2-6, 2021
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 18 non-derivative transactions. Open-market purchases total $92.0K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Ramsay David ACIK 0001283292Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 2, 2021Common StockPPurchaseAcquired+1,601$3.69+$5,907.6977,101Direct
Dec 2, 2021Common StockPPurchaseAcquired+2,000$3.70+$7,40079,101Direct
Dec 2, 2021Common StockPPurchaseAcquired+1,000$3.71+$3,71080,101Direct
Dec 2, 2021Common StockPPurchaseAcquired+1,100$3.73+$4,10381,201Direct
Dec 2, 2021Common StockPPurchaseAcquired+2,400$3.74+$8,97683,601Direct
Dec 2, 2021Common StockPPurchaseAcquired+1,000$3.78+$3,78084,601Direct
Dec 2, 2021Common StockPPurchaseAcquired+1,000$3.80+$3,80085,601Direct
Dec 3, 2021Common StockPPurchaseAcquired+2,000$3.63+$7,26087,601Direct
Dec 3, 2021Common StockPPurchaseAcquired+399$3.64+$1,452.3688,000Direct
Dec 3, 2021Common StockPPurchaseAcquired+1,000$3.68+$3,68089,000Direct
Dec 3, 2021Common StockPPurchaseAcquired+1,000$3.69+$3,69090,000Direct
Dec 6, 2021Common StockPPurchaseAcquired+1,000$3.75+$3,75091,000Direct
Dec 6, 2021Common StockPPurchaseAcquired+785$3.77+$2,959.4591,785Direct
Dec 6, 2021Common StockPPurchaseAcquired+1,000$3.80+$3,80092,785Direct
Dec 6, 2021Common StockPPurchaseAcquired+1,000$3.81+$3,81093,785Direct
Dec 6, 2021Common StockPPurchaseAcquired+2,215$3.82+$8,461.396,000Direct
Dec 6, 2021Common StockPPurchaseAcquired+1,000$3.84+$3,84097,000Direct
Dec 6, 2021Common StockPPurchaseAcquired+3,000$3.87+$11,610100,000Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)